
The Joint Corp. Stock Plummets to New 52-Week Low at $7.50
2025-11-10 17:18:34The Joint Corp. has reached a new 52-week low, reflecting a significant decline of 48.45% over the past year, contrasting with the S&P 500's gains. The company, with a market cap of USD 164 million, faces challenges indicated by negative return on equity and a high price-to-book ratio.
Read More
The Joint Corp. Hits New 52-Week Low at $7.69 Amid Decline
2025-11-05 16:48:17The Joint Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 7.69, reflecting a challenging year with a 46.98% decline in stock price. The company has a market cap of USD 164 million and shows negative financial metrics, including a return on equity of -13.76%.
Read More
The Joint Corp. Hits 52-Week Low at $7.74 Amidst Significant Decline
2025-11-03 17:14:33The Joint Corp. has reached a new 52-week low, reflecting a challenging year with a significant performance decline. Despite a reported profit increase, the company's financial metrics indicate a complex structure, including a negative return on equity and a high price-to-book ratio, contributing to its current market position.
Read More
The Joint Corp. Hits New 52-Week Low at $7.78 Amid Decline
2025-10-31 16:24:49The Joint Corp. has reached a new 52-week low of USD 7.78, reflecting a challenging year with a 46.98% decline from its high of USD 13.47. Despite a 44.8% increase in profits, the company has struggled with negative stock performance and underperformed against the S&P 500.
Read More
The Joint Corp. Stock Plummets to New 52-Week Low at $8.62
2025-10-09 20:20:30The Joint Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. With a market capitalization of USD 164 million, the company faces financial challenges, including a negative return on equity and a high price-to-book ratio, indicating ongoing difficulties in the market.
Read More
The Joint Corp. Hits 52-Week Low at $8.67 Amidst Ongoing Struggles
2025-10-08 16:54:07The Joint Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low of USD 8.67 as of October 7, 2025. The company has a market cap of USD 164 million and operates at a loss, with significant financial challenges reflected in its ratios and stock performance.
Read More
The Joint Corp. Hits 52-Week Low at USD 8.74 Amid Declining Performance
2025-10-07 21:56:12The Joint Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a 40.66% decline over the past year. With a market cap of USD 164 million, the company faces financial challenges, including negative earnings and a high price-to-book ratio.
Read More
The Joint Corp. Hits New 52-Week Low at $8.93 Amid Decline
2025-10-06 17:38:24The Joint Corp. has reached a new 52-week low of USD 8.93, reflecting a significant decline in its stock price, which has dropped by nearly 39% over the past year. Despite a 44.8% increase in profits, the company continues to face challenges in the market.
Read More
The Joint Corp. Stock Plummets to New 52-Week Low at $9.06
2025-10-02 22:38:37The Joint Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year, contrasting with the S&P 500's gains. The company operates at a loss, with a high price-to-book ratio and negative return on equity, indicating financial challenges despite increased profits.
Read More





